181 related articles for article (PubMed ID: 26366213)
1. The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling.
Sun G; Mackey LV; Coy DH; Yu CY; Sun L
J Cancer; 2015; 6(10):996-1004. PubMed ID: 26366213
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.
Sun L; Qian Q; Sun G; Mackey LV; Fuselier JA; Coy DH; Yu CY
J Drug Target; 2016; 24(2):169-77. PubMed ID: 26211366
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II.
Sun L; He Q; Tsai C; Lei J; Chen J; Vienna Makcey L; Coy DH
Am J Transl Res; 2018; 10(2):545-553. PubMed ID: 29511449
[TBL] [Abstract][Full Text] [Related]
4. Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.
Franko-Tobin LG; Mackey LV; Huang W; Song X; Jin B; Luo J; Morris LM; Liu M; Fuselier JA; Coy DH; Wu L; Sun L
Oncologist; 2012; 17(2):220-32. PubMed ID: 22291092
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid exhibits different cell growth arrest effect in three HPV-positive/negative cervical cancer cells and possibly via inducing Notch1 cleavage and E6 downregulation.
Feng S; Yang Y; Lv J; Sun L; Liu M
Int J Oncol; 2016 Jul; 49(1):422-30. PubMed ID: 27176495
[TBL] [Abstract][Full Text] [Related]
6. Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.
Zhu B; Sun L; Luo W; Li M; Coy DH; Yu L; Yu W
Oncotarget; 2017 Apr; 8(14):23289-23302. PubMed ID: 28423575
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II.
Tsai C; Leslie JS; Franko-Tobin LG; Prasnal MC; Yang T; Vienna Mackey L; Fuselier JA; Coy DH; Liu M; Yu C; Sun L
Arch Gynecol Obstet; 2013 Aug; 288(2):393-400. PubMed ID: 23435724
[TBL] [Abstract][Full Text] [Related]
8. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid induces Notch1 signaling in small cell lung cancer cells.
Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H
J Surg Res; 2008 Jul; 148(1):31-7. PubMed ID: 18570928
[TBL] [Abstract][Full Text] [Related]
10. Combination of sorafenib and Valproic acid synergistically induces cell apoptosis and inhibits hepatocellular carcinoma growth via down-regulating Notch3 and pAkt.
Zhu W; Liang Q; Yang X; Yu Y; Shen X; Sun G
Am J Cancer Res; 2017; 7(12):2503-2514. PubMed ID: 29312803
[TBL] [Abstract][Full Text] [Related]
11. Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells.
Tatebe H; Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Tsurumi H; Moriwaki H
Cancer Lett; 2009 Nov; 285(2):210-7. PubMed ID: 19520494
[TBL] [Abstract][Full Text] [Related]
12. Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells.
Saha SK; Yin Y; Kim K; Yang GM; Dayem AA; Choi HY; Cho SG
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498322
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid, a histone deacetylase inhibitor, regulates cell proliferation in the adult zebrafish optic tectum.
Dozawa M; Kono H; Sato Y; Ito Y; Tanaka H; Ohshima T
Dev Dyn; 2014 Nov; 243(11):1401-15. PubMed ID: 25091230
[TBL] [Abstract][Full Text] [Related]
14. Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2.
Sun L; Liu M; Sun GC; Yang X; Qian Q; Feng S; Mackey LV; Coy DH
J Cancer; 2016; 7(11):1388-95. PubMed ID: 27471554
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Effect of the Histone Deacetylase Inhibitor Valproic Acid on Viability and Apoptosis of the PLC/PRF5 Human Hepatocellular Carcinoma Cell Line.
Sanaei M; Kavoosi F; Roustazadeh A; Shahsavani H
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2507-2510. PubMed ID: 30256044
[TBL] [Abstract][Full Text] [Related]
18. Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation.
Yu JI; Choi C; Shin SW; Son A; Lee GH; Kim SY; Park HC
Sci Rep; 2017 Nov; 7(1):14986. PubMed ID: 29118323
[TBL] [Abstract][Full Text] [Related]
19. Activation of the intrinsic apoptosis pathway contributes to the induction of apoptosis in hepatocellular carcinoma cells by valproic acid.
Yang W; Zhao X; Pei F; Ji M; Ma W; Wang Y; Jiang G
Oncol Lett; 2015 Feb; 9(2):881-886. PubMed ID: 25621063
[TBL] [Abstract][Full Text] [Related]
20. Antitumor Effect of Pseudolaric Acid B Involving Regulation of Notch1/Akt Signaling Response in Human Hepatoma Cell In Vitro.
Gao H; Zhang Y; Mo X; Huo L; Luo Y; Zhang T; Ma X; Hu W; Jing T
Evid Based Complement Alternat Med; 2022; 2022():5353686. PubMed ID: 35747382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
